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Summary
Ras proteins play a central role in transducing signals that
control cell proliferation, differentiation, motility, and sur-
vival. The location-specific signaling activity of Ras has
been previously shown to be regulated by ubiquitination
[1]. However, the molecular machinery that controls Ras
ubiquitination has not been defined. Here we demonstrate
through biochemical and functional analyses that Rabex-5
(also known as RabGEF1) [2, 3] functions as an E3 ligase
for Ras. Rabex-5-mediated Ras ubiquitination promotes
Ras endosomal localization and leads to the suppression
of ERK activation. Moreover, the Ras effector RIN1 [4, 5] is
required for Rabex-5-dependent Ras ubiquitination, sug-
gesting a feedback mechanism by which Ras activation
can be coupled to ubiquitination. These findings define
new elements in the regulatory circuitry that link Ras
compartmentalization to signaling output.
Results and Discussion
Rabex-5 Catalyzes Ras Ubiquitination
Ras proteins (HRas, NRas, and KRas) are small guanine nucle-
otide-binding proteins that mediate the transduction of signals
from diverse extracellular stimuli to intracellular signaling
pathways that control fundamental cellular functions including
proliferation, differentiation, and survival. It is now well estab-
lished that Ras proteins can dynamically partition to different
cellular membranes. Although all Ras isoforms are found at
the plasma membrane, HRas and NRas are also present at
the Golgi and endosomes, whereas KRas can be found in the
endoplasmic reticulum and the outermitochondrial membrane
[6, 7]. Significantly, Ras compartmentalization dictates its sig-
naling capacity and leads to distinct biological outcomes. For
example, activation of Ras at the plasmamembrane is fast and
transient, whereas activation of Ras in the Golgi is delayed and
sustained [8]. Moreover, in T cells, Ras resides in both the
plasma membrane and Golgi; however, it is the activation of
the Ras-ERK pathway in the Golgi pool that is essential in
specifying the functional T cell population [9]. Finally, mito-
chondrial KRas induces apoptosis through its association
with Bcl-XL [10].
Several mechanisms have been implicated in the control of
Ras intracellular trafficking. KRas, which resides predomi-
nantly in the plasma membrane, is transiently redistributed
to intracellular membranes by phosphorylation-dependent
alterations of electrostatic interactions with the plasma mem-
brane [10]. HRas and NRas undergo a constitutive depalmitoy-
lation/repalmitoylation cycle, which leads to their continuous*Correspondence: dafna.bar-sagi@nyumc.orgshuttling between the plasma membrane and the Golgi
[11, 12]. We have shown that, in mammalian cells, HRas and
NRas are subject to mono- and diubiquitination and that
this modification promotes their endosomal association,
thereby leading to the attenuation of Ras-ERK signaling [1].
Consistent with these findings, it has been recently reported
that in Drosophila, maintaining a threshold of Ras ubiquitina-
tion is critical to prevent inappropriate Ras-ERK activation
in vivo [13].
To gain insights into themechanisms that regulate Ras ubiq-
uitination, we sought to determine the identity of the E3 ligase
that catalyzes this reaction. We focused on Rabex-5, the
mammalian ortholog of yeast Vps9p and a guanine nucleotide
exchange factor (GEF) for Rab5 [2, 3]. In addition to its GEF
activity, Rabex-5 has been shown to possess an E3 ubiquitin
ligase activity mediated by an amino-terminal zinc finger
(ZnF) domain that belongs to the A20 ZnF family [14–16].
This catalytic activity, along with the observation that Rabex-
5 binds to Ras [17], prompted us to investigate the role of
Rabex-5 in the regulation of Ras ubiquitination.
We first examined whether Rabex-5 can promote Ras
ubiquitination. As shown, the overexpression of Rabex-5 in
HEK293T cells induced the accumulation of mono- and diubi-
quitinated species of ectopically expressed HRas (Figure 1A;
see also Figure S1A available online), in agreement with the
pattern of Ras ubiquitination reported previously [1]. Similar
results were obtained by using different cell types (such as
COS-1 [Figure S1B] and HeLa [data not shown]), as well as
by using an alternative method to isolate and detect ubiquiti-
nated Ras species (Figure S1C). Consistent with the ectopic
expression data, the mono- and diubiquitination of endoge-
nous Ras was also stimulated by the overexpression of
Rabex-5 (Figure 1B). To test whether this effect was depen-
dent on the ligase activity of Rabex-5, we used a Rabex-5
mutant (Rabex-5 AA) that is impaired in ligase activity because
of Tyr-to-Ala substitutions in residues 25 and 26, which com-
promise ubiquitin binding [15]. Rabex-5 AA retained a Ras-
binding activity (Figure S1D) but was ineffective in stimulating
Ras ubiquitination (Figure 1B). Thus, the most plausible inter-
pretation of our findings is that Rabex-5 promotes Ras ubiqui-
tination by functioning as its ubiquitin ligase.
To further test this idea, we investigated whether Rabex-5
can directly catalyze the ubiquitination of Ras. To this end,
we performed an in vitro ubiquitination assay using recombi-
nant His-HRas and GST-Rabex-5 proteins. It has been re-
ported that, when purified as a recombinant protein, full-length
Rabex-5 is conformationally unstable [18–20]. Therefore, we
employed a recombinant fragment of Rabex-5 (residues 1–76)
that encompasses the ubiquitin ligase domain and has been
successfully utilized before in in vitro ubiquitination assays
[14, 15]. The suitability of this fragment for use in our experi-
ments is further supported by the observations that it lies
within one of theRas binding determinants of Rabex-5 [17] and
can interact with Ras directly in vitro (Figure S1E). As shown in
Figure 1C, Rabex-5 stimulated the ubiquitination of HRas
in vitro, whereas Rabex-5 AA was compromised in promoting
HRas ubiquitination. Similar results were obtained using
a complementary approach (Figure S1F). Notably, Rabex-5
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Figure 1. Rabex-5 Ubiquitinates HRas
(A) HEK293T cells were cotransfected with expression vectors for His6-tagged ubiquitin (His-Ub), HA-tagged Rabex-5 wild-type (WT), and T7-tagged HRas
WT, as indicated. Ub conjugates were isolated from the transfected cells by nickel-nitrilotriacetic acid (Ni-NTA) affinity chromatography, and HRas polypep-
tides were detected by immunoblotting (IB).
(B) HEK293T cells were cotransfected with expression vectors for His-Ub and HA-tagged Rabex-5 WT or a ligase-defective Rabex-5 mutant Y25A/Y26A
(AA). The ubiquitination of endogenous Ras was analyzed as in (A).
(C) In vitro ubiquitination assay was performed by incubating recombinant GST-tagged Rabex-5 WT or AA (residues 1–76) and recombinant His-tagged
HRas in the presence of E1, E2 (UbcH5c), and N-terminal biotinylated Ub. His-tagged HRas was isolated by Ni-NTA affinity chromatography, and biotiny-
lated Ub conjugates were detected by avidin-biotin complex-horseradish peroxidase (ABC-HRP).
(D) COS-1 cells were transfected with constructs encoding a scramble short hairpin RNA (shRNA) sequence or shRNA sequences targeting Rabex-5.
Following blasticidin S selection, the cells were cotransfectedwith His-Ub, T7-HRasG12V, and the indicated shRNA-resistant Rabex-5 constructs (Wobble).
The ubiquitination of HRas G12V was analyzed as in (A).
See also Figure S1. In this and all other figures, levels of endogenous or ectopically expressed proteins were determined by immunoblotting of whole cell
lysates (WCL), numbers shown to the left of the blots are molecular masses in kDa, and all results shown are representative of three independent experi-
ments.
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1373failed to ubiquitinate Rab5, both in vivo (Figure S1G) and
in vitro (Figure S1F). Together, these findings indicate that
HRas is a direct and specific substrate for Rabex-5.
To determine whether Rabex-5 is essential for Ras ubiquiti-
nation in vivo, we investigated whether Rabex-5 silencing
suppresses Ras ubiquitination. The capacity to detect a sig-
nificant level of Ras ubiquitination under conditions of endog-
enous Rabex-5 expression is a prerequisite for this assay.
Because the ubiquitination signal of wild-type (WT) HRas is
barely detectable under basal conditions (Figure 1A; Fig-
ure S1B), we resorted to the use of activated HRas (HRas
G12V), which, for reasons delineated below (see Figure 4F),
displays a robust ubiquitination even in the absence of
Rabex-5 overexpression. Transfection of small hairpin RNA
(shRNA) against Rabex-5 was accompanied by suppression
of HRas ubiquitination, and this effect could be rescued by
the overexpression of shRNA-resistant Rabex-5 WT, but not
Rabex-5 AA, constructs (Figure 1D). We conclude that Ras
ubiquitination in vivo is predominantly controlled by Rabex-5.
Rabex-5-Mediated Ubiquitination Controls the Endosomal
Partitioning of Ras
Mono- and diubiquitination of plasma membrane proteins
serve as a signal for endosomal sorting [21, 22]. Accordingly,
we have shown that the ubiquitination of HRas promotes itsendosomal association [1]. Because Rabex-5 regulates the
ubiquitination of HRas, we predicted that the partitioning of
Ras to the endocytic compartment would be augmented in
the presence of Rabex-5. To test this prediction, we analyzed
the effect of Rabex-5 overexpression on HRas localization
by fluorescence microscopy. Under basal conditions, GFP-
HRas displayed a characteristic distribution pattern with
prominent presence on the plasma membrane and Golgi (Fig-
ure 2A). Upon Rabex-5 overexpression, a significant enhance-
ment of endosome-associated GFP-HRas was detected (Fig-
ures 2B and 2D). Conversely, depletion of Rabex-5 by shRNA
resulted in reduced levels of endosomal GFP-HRas (Fig-
ure S2A). The endosomal identity of the GFP-HRas-labeled
vesicular structures was ascertained using the early endoso-
mal marker EEA1 (Figure 2E). The majority of the GFP-HRas-
labeled endosomes were also Rabex-5 positive (Figures 2B
and 2E), consistent with the documented physical interactions
between the two proteins [17] and the notion that Ras is
a substrate of Rabex-5. Moreover, because Rabex-5 resides
mostly in the early endosomes (Figure 2E) [23], it is possible
that the ubiquitination of Ras takes place at the endosomal
membrane and, if so, that it would function as an endosomal
retention rather than endosomal targeting signal.
As a GEF for Rab5, Rabex-5 promotes endosomal fusion
[2, 18], as reflected by the accumulation of enlarged
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Figure 2. Rabex-5 Increases the Endosomal Pool of HRas
(A) COS-1 cells were transfected with expression vectors for GFP-HRas, HA-tagged Rabex-5 WT, or a guanine nucleotide exchange factor (GEF)-defective
Rabex-5 mutant (Rabex-5 D313A) and were immunostained with mouse anti-HA.
(B) COS-1 cells were cotransfected with GFP-HRas and HA-Rabex-5 (red) and immunostained as in (A). The inset in the ‘‘Merge’’ panel represents an
enlargement of the boxed area.
(C) COS-1 cells were cotransfected with GFP-HRas and HA-Rabex-5 D313A (red) and immunostained as in (A). The bottom panels represent enlargements
of the boxed areas in the top panels.
(D) Quantification of Rabex-5-dependent endosomal recruitment of HRas. The percentage of cells with HRas localized to the endocytic compartment is
shown. Values represent means 6 standard deviation (SD) from three independent experiments.
(E) COS-1 cells transfected with GFP-HRas and HA-Rabex-5 WT were stained with rabbit anti-HA (red), mouse anti-EEA1, and DAPI (blue).
Images for all panels represent a single 0.2 mm deconvolved Z section. Scale bar represents 10 mm. See also Figure S2.
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1374endosomes in Rabex-5-expressing cells (Figures 2A, 2B, and
2E; Figure S2B). To rule out the possibility that the Rabex-5-
dependent accumulation of HRas in the endosomes is due to
a general stimulatory effect of Rabex-5 on endosomal traf-
ficking, we examined the localization of GFP-HRas in the pres-
ence of a Rabex-5 mutant that was rendered defective in GEF
activity by a mutation in the Vps9 domain [3, 23]. As previously
demonstrated [23], this mutant (Rabex-5 D313A) was localized
to endosomes, albeit of smaller size relative to Rabex-5 WT-
containing endosomes (Figure 2A). Significantly, this mutant,
which possesses Ras ubiquitination activity (Figure S2C),
retained the ability to enhance Ras endosomal association
(Figures 2C and 2D). Hence, by acting as a ubiquitin ligase for
Ras, Rabex-5 tightly controls the pool size of endosomal Ras.
Rabex-5-Mediated Ubiquitination Attenuates Ras-Induced
ERK Activation
We have previously demonstrated that HRas ubiquitination,
and the resulting endosomal retention, negatively regulatesRas-dependent recruitment of Raf to the plasma membrane
and ERK activation [1]. Given the role of Rabex-5 in promoting
HRas ubiquitination and endosomal association, we surmised
that ERK activation by Ras would be attenuated by overex-
pressing Rabex-5. As illustrated in Figure 3A and Figure S3A,
the overexpression of Rabex-5 WT or Rabex-5 D313A led to
the suppression of HRas-induced ERK activation, indicating
that this effect is independent of the GEF activity of Rabex-5.
In contrast, the ligase activity of Rabex-5 is essential for its
attenuating effect on HRas-induced ERK activation, as indi-
cated by the observation that this effect was not exhibited
by Rabex-5 AA or Rabex-5 D313A/AA mutants (Figure 3A;
Figure S3A). Significantly, Yan et al. ([24], this issue of Current
Biology) have implicated the ubiquitin ligase activity of
Drosophila Rabex-5 in restricting Ras signaling in vivo. Thus,
the functional consequences of Rabex-5-mediated Ras ubiq-
uitination appear to be highly conserved.
To substantiate the link between Rabex-5-mediated Ras
ubiquitination and downstream ERK signaling, we took
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Figure 3. Rabex-5 Attenuates Ras-Induced ERK
Activation
(A) COS-1 cells were transfected with HA-tagged
ERK2 and the indicated Rabex-5 constructs in
the absence or presence of T7-tagged HRas or
KRas. Transfected ERK2 was isolated by immu-
noprecipitation (IP), and activation was deter-
mined by immunoblotting (IB) with rabbit anti-
phospho-ERK antibodies (pERK2) and mouse
anti-ERK2 antibodies (ERK2) on the same mem-
branes. Quantification was carried out by two-
color Odyssey infrared imaging system (bottom;
see also Figure S3A). Values shown represent
means 6 SD from three independent experi-
ments. a.u. denotes arbitrary units. A paired
Student’s t test was performed using the two-
tailed distribution. **p < 0.01.
(B) COS-1 cells were transfected with His-Ub,
HA-Rabex-5, and T7-tagged HRas or KRas, as
indicated, and Ras ubiquitination was analyzed
as in Figure 1A. See also Figure S3B.
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1375advantage of a previous finding that Ras ubiquitination dis-
plays isoform specificity. In particular, we have shown that
KRas is not modified by ubiquitination [1]. Consistent with
this finding, the overexpression of Rabex-5 did not induce
KRas ubiquitination (Figure 3B). Moreover, KRas-mediated
ERK activation was not affected by Rabex-5 overexpression
(Figure 3A), confirming that the negative effect exerted by
Rabex-5 on HRas signaling ismediated by its HRas ubiquitina-
tion activity. It should be noted that NRas, which has been
previously shown to be ubiquitinated [1], is also a target for
Rabex-5-mediated ubiquitination (Figure S3B) and thus, in
principle, could be subjected to a similar mode of regulation.
RIN1 IsRequired forRabex-5-MediatedHRasUbiquitination
Rabex-5 has been shown to bind to the Rab5 effector Rabap-
tin-5 [2]. This interaction serves to recruit Rabex-5 to early
endosomes in a Rab5-dependent manner via the interaction
of Rabaptin-5 with Rab5-GTP [18]. In mammalian cells, the
levels of Rab5-GTP are positively regulated not only by Ra-
bex-5 but also by the Rab5 GEF proteins of the RIN family,
the best characterized of which is RIN1 [25]. Therefore, we
sought to determine whether RIN1 participates in the regula-
tion of Ras ubiquitination. RIN1 overexpression stimulated
the ubiquitination of HRas (Figure 4A), and conversely, HRas
ubiquitination was reduced to basal levels upon small inter-
fering RNA (siRNA)-mediated suppression of RIN1 expression
(Figure 4B). Moreover, RIN1-mediated HRas ubiquitination is
Rabex-5 dependent, as indicated by the failure of RIN1 toenhance HRas ubiquitination upon sup-
pression of Rabex-5 (Figure 4C). Thus,
RIN1 appears to be an essential compo-
nent of the regulatory cascade that
controls Ras ubiquitination. This newly
identified function for RIN1 might
account, at least in part, for its reported
activity as a negative regulator of Ras
signaling [4].
To further investigate the mechanism
by which RIN1 participates in the regula-
tion of HRas ubiquitination, we tested
the effect on HRas ubiquitination of a
RIN1 mutant, RIN1 E574A [26], that isdefective in Rab5 GEF activity. As illustrated in Figure 4D,
the Rab5 GEF activity of RIN1 was required for its promoting
effect on HRas ubiquitination. Hence, it appears that RIN1-
mediated activation of Rab5 serves as a prerequisite for Ra-
bex-5-dependent HRas ubiquitination. This idea is supported
by the finding that the dependence of HRas ubiquitination on
RIN1 could be obviated by the expression of a constitutively
active form of Rab5, Rab5 Q79L (Figure S4A). Moreover,
Rab5 Q79L stimulated HRas ubiquitination in a Rabex-5-
dependent manner (Figure S4B). Together, these data are
consistent with a model in which RIN1, through its function
as a Rab5 GEF, promotes the Rab5-GTP-dependent recruit-
ment of Rabaptin-5/Rabex-5 complex to endosomal sites
where HRas ubiquitination takes place.
In addition to its function as a GEF for Rab5, RIN1 is a Ras
effector [4, 5]. It directly interacts with GTP-bound Ras through
a canonical Ras association domain, and this interaction
potentiates RIN1 GEF activity [27]. The role of RIN1 in pro-
moting Ras ubiquitination along with its Ras effector function
raises the intriguing possibility that Ras ubiquitination might
be subject to feedback regulation through the activation of
the RIN1/Rab5/Rabex-5 axis. To test this idea, we differentially
tagged HRas WT and HRas G12V with T7 and HA epitopes,
respectively, and coexpressed them in COS-1 cells. As illus-
trated in Figure 4E, the level of ubiquitination of HRas WT was
significantly enhanced in the presence of HRas G12V, indi-
cating that HRas activation can promote HRas ubiquitination.
The link between HRas activation and the status of HRas
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Figure 4. RIN1 Is Required for Rabex-5-Mediated HRas Ubiquitination
(A–F) COS-1 cells were transfected as indicated, and HRas ubiquitination was analyzed as in Figure 1A.
(A) Cells were cotransfected with His-Ub and T7-HRas WT in the absence or presence of HA-tagged RIN1.
(B) Cells were first transfected with nontargeting (control) or RIN1 small interfering RNA (siRNA) duplexes and then with His-Ub and T7-HRas G12V.
(C) Cells were transfected with scramble or Rabex-5 shRNAs. Following blasticidin S selection, the cells were transfected with His-Ub and T7-HRas WT in
the absence or presence of HA-RIN1 construct.
(D) Cells were cotransfected with His-Ub, T7-HRas WT, and RIN1 WT or the GEF-defective RIN1 mutant E574A.
(E) Cells were transfected with T7-tagged HRas WT and HA-tagged HRas G12V as indicated, along with His-Ub.
(F) Cells were transfected with His-Ub and T7-tagged HRas WT or HRas G12V constructs as indicated.
See also Figure S4.
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1376ubiquitination also predicts that HRas G12V would be prefer-
entially ubiquitinated relative to HRas WT. Indeed, at basal
conditions, the level of HRas G12V ubiquitination is appre-
ciably higher in comparison to HRas WT (Figure 4F). A similar
difference has been observed in HEK293T andHeLa cells (data
not shown). HRasWT and HRas G12V displayed similar in vivo
interactions with Rabex-5 (Figure S4C), ruling out differential
Rabex-5 binding as the mechanism underlying the preferential
ubiquitination of HRas G12V. Of note, this result is at variance
with our previous demonstration of no significant differences
between the level of ubiquitination of HRas WT and HRas
G12V in Chinese hamster ovary cells [1]. As we have proposed
previously, it is conceivable that in these cells the differences
might be obscured because of altered relative stoichiometries
of one or more of the regulatory components that control Ras
ubiquitination.
In summary, our study identifies Ras as a target of the E3
ligase Rabex-5. By promoting Ras ubiquitination and endoso-
mal association, Rabex-5 can function to dynamically shift
the partitioning of Ras between different membrane compart-
ments, thereby contributing to the spatial control of Ras-
dependent cellular responses. The Rab5 GEF activity of
Rabex-5 has also been implicated in the control of receptor-
mediated Ras signaling through the modulation of receptor
endocytosis [23]. Hence, the dual function of Rabex-5 as an
E3 ligase for Ras and as a GEF for Rab5 provides a molecular
platform for the integration of endocytic trafficking and
signaling.Experimental Procedures
Human Rabex-5 and RIN1 cDNAs were cloned from MIA PaCa-2 and HeLa
cells, respectively. COS-1 and HEK293T cells were transfected usingFugene 6 Reagent (Roche Applied Science) and Lipofectamine 2000
(Invitrogen), respectively. After 1 day, the transfected cells were harvested
and in vivo Ras ubiquitination was analyzed by Ni-NTA affinity chromatog-
raphy, as previously described [1]. In vitro ubiquitination assayswere carried
out by incubating the following components at 30C for 2 hr: biotin-N-
terminal ubiquitin, ubiquitin-activating enzyme (UBE1), E2 (UbcH5C), human
recombinant GST-Rabex-5 (1–76), and His-HRas. Following purification by
Ni-NTA affinity chromatography, the biotinylated ubiquitin conjugates
were then probed with ABC-HRP (Vector Laboratories) and detected using
ECL (Pierce). Rabex-5 was knocked down by transfecting COS-1 cells with
DNA-directed shRNA using pcDNA/SUPER vector and selecting with blas-
ticidin S. RIN1 was knocked down by transfecting COS-1 cells with a pool of
siRNA duplexes (Dharmacon). For immunofluorescence analyses, COS-1
cells were transfected, fixed, and stained as previously described [1]. ERK
activation assay was performed by immunoprecipitation of HA-ERK2, fol-
lowed by immunoblot analysis using phospho-ERK antibody, as previously
described [1]. A detailed description of the experimental procedures is
reported in the Supplemental Experimental Procedures.Supplemental Information
Supplemental Information includes Supplemental Experimental Procedures
and four figures and can be found with this article online at doi:10.1016/
j.cub.2010.06.051.Acknowledgments
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